
Pharma Pulse 6/5/24: Pediatric Weight Crucial to Perfecting the Dose, AI Employees Aren’t Free to Voice Concerns & more
The latest news for pharma industry insiders.
A retrospective study explores the connection between adherence and racial/ethnic disparities among patients with Alzheimer’s disease, along with similar dementias.
Evidence indicates that up to 25% of all prescriptions for children could be dosed inappropriately, making it the most common type of medication administration error.
Industry experts, in a roundtable discussion, explore the evolution of brand engagement in the age of AI, including the growing importance of message relevance—and, for pharma, going where the information is.
A group of current and former OpenAI and DeepMind employees want more whistleblower protections and fear retaliation.
Funding provided to school-based telehealth provider Hazel Health, who will partner with school systems across Iowa to enable access to mental health support for approximately 100,000 K-12 students
Great to see my friend Cheryl Mahon who works on Pharmaceutical Commerce Magazine, Pharmaceutical Executive and Applied Clinical Trials Magazine! Whew! At MJH Life Sciences®
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

